Palliative Care in Improving Quality of Life in Patients With Newly Diagnosed Pancreatic Cancer



Status:Recruiting
Conditions:Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:21 - Any
Updated:7/11/2015
Start Date:November 2014

Use our guide to learn which trials are right for you!

Feasibility of an Interdisciplinary Palliative Care Planning Intervention in Pancreatic Cancer

This pilot clinical trial studies a palliative care program in improving the quality of life
of patients with newly diagnosed pancreatic cancer. Palliative care is care given to
patients who have a serious or life-threatening disease, and focuses on managing disease
symptoms, side effects of treatment or the disease, and improving patient quality of life.
Studying a palliative care program used for other types of cancer may help doctors learn
whether it can improve the quality of life of patients with pancreatic cancer.

PRIMARY OBJECTIVES:

I. To pilot-test an interdisciplinary Palliative Care Planning Intervention (PCPI) in
pancreatic cancer. Specifically, to describe patients' satisfaction with the timing,
content, and delivery of the PCPI intervention.

SECONDARY OBJECTIVES:

I. To pilot-test all selected measures for the study, including measures for healthcare
resource utilization, overall cost, and patient/family out of pocket expenses.

II. The long-term objective of this pilot study is to conduct a larger PCPI intervention
study for pancreatic cancer patients and evaluate its impact on quality of life (QOL),
symptom intensity, healthcare resource utilization, and healthcare costs.

OUTLINE:

Patients receive a handbook titled "Supporting You During Cancer Treatment" with educational
material on QOL issues. Patients undergo 2 education sessions on handbook material in-person
or by telephone, with session 1 focusing on physical and social well-being issues and
session 2 focusing on psychological and spiritual well-being issues. At the beginning of
each session, patients select 3 priority topics from a list, and content is tailored to
patient needs.

After completion of study, patients are followed up at 1 and 2 months.

Inclusion Criteria:

- Pathologically confirmed, new diagnosis of borderline resectable, locally advanced
resectable/unresectable, or metastatic pancreatic cancer

- Patients who are scheduled to receive treatments (neoadjuvant therapy, surgery,
adjuvant therapy, or palliative chemotherapy) at City of Hope (COH)

- All subjects must have the ability to understand and the willingness to provide
informed consent

Exclusion Criteria:

- Subjects, who in the opinion of the investigator, may not be able to comply with the
safety monitoring requirements of the study
We found this trial at
1
site
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
City of Hope National Medical Center City of Hope is dedicated to making a difference...
?
mi
from
Duarte, CA
Click here to add this to my saved trials